N
PMC

Natixis’s PharMerica Corporation PMC Stock Holding History

Natixis’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-13,900
Closed -$193K – 589
2013
Q2 		$193K Buy
+13,900
New +$197K ﹤0.01% 408

Other funds holding PMC

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
KIM
Kestrel Investment Management San Mateo, California $167M AUM 20.81% 1-Year Est. Return

Natixis's PMC Position: Q3 2013 in Review

Natixis sold out of PharMerica Corporation (PMC) in Q3 2013, closing a stake of 13,900 shares — an estimated $193K sold.

Natixis first reported a position in PMC in Q2 2013 and held it in 1 quarter. The position peaked at $193K in Q2 2013. 147 funds tracked by Wall St. Rank hold PMC as of Q3 2013.

  • Natixis reported no remaining PharMerica Corporation position as of Q3 2013 after selling out during the quarter.
  • Natixis sold 13,900 PharMerica Corporation shares in Q3 2013, an estimated $193K.
  • Natixis first reported a position in PharMerica Corporation in Q2 2013 and held it in 1 quarter.
  • Natixis's PharMerica Corporation position peaked at $193K in Q2 2013.
  • 147 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2013.

Based on Natixis's 13F filing for Q3 2013, filed 14 Nov 2013.